Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2008 1
2009 2
2010 3
2011 3
2012 5
2013 3
2014 2
2016 3
2017 6
2018 6
2019 1
2020 8
2021 5
2022 7
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Whole-mouse clearing and imaging at the cellular level with vDISCO.
Cai R, Kolabas ZI, Pan C, Mai H, Zhao S, Kaltenecker D, Voigt FF, Molbay M, Ohn TL, Vincke C, Todorov MI, Helmchen F, Van Ginderachter JA, Ertürk A. Cai R, et al. Among authors: vincke c. Nat Protoc. 2023 Apr;18(4):1197-1242. doi: 10.1038/s41596-022-00788-2. Epub 2023 Jan 25. Nat Protoc. 2023. PMID: 36697871 Review.
AAV-mediated delivery of an anti-BACE1 VHH alleviates pathology in an Alzheimer's disease model.
Marino M, Zhou L, Rincon MY, Callaerts-Vegh Z, Verhaert J, Wahis J, Creemers E, Yshii L, Wierda K, Saito T, Marneffe C, Voytyuk I, Wouters Y, Dewilde M, Duqué SI, Vincke C, Levites Y, Golde TE, Saido TC, Muyldermans S, Liston A, De Strooper B, Holt MG. Marino M, et al. Among authors: vincke c. EMBO Mol Med. 2022 Apr 7;14(4):e09824. doi: 10.15252/emmm.201809824. Epub 2022 Mar 30. EMBO Mol Med. 2022. PMID: 35352880 Free PMC article.
A few good reasons to use nanobodies for cancer treatment.
Jumapili NA, Zivalj M, Barthelmess RM, Raes G, De Groof TWM, Devoogdt N, Stijlemans B, Vincke C, Van Ginderachter JA. Jumapili NA, et al. Among authors: vincke c. Eur J Immunol. 2023 Sep;53(9):e2250024. doi: 10.1002/eji.202250024. Epub 2023 Jun 27. Eur J Immunol. 2023. PMID: 37366246 Review.
Size-advantage of monovalent nanobodies against the macrophage mannose receptor for deep tumor penetration and tumor-associated macrophage targeting.
Erreni M, D'Autilia F, Avigni R, Bolli E, Arnouk SM, Movahedi K, Debie P, Anselmo A, Parente R, Vincke C, van Leeuwen FWB, Allavena P, Garlanda C, Mantovani A, Doni A, Hernot S, Van Ginderachter JA. Erreni M, et al. Among authors: vincke c. Theranostics. 2023 Jan 1;13(1):355-373. doi: 10.7150/thno.77560. eCollection 2023. Theranostics. 2023. PMID: 36593955 Free PMC article.
Nanobodies for the Early Detection of Ovarian Cancer.
Tran LH, Graulus GJ, Vincke C, Smiejkowska N, Kindt A, Devoogdt N, Muyldermans S, Adriaensens P, Guedens W. Tran LH, et al. Among authors: vincke c. Int J Mol Sci. 2022 Nov 8;23(22):13687. doi: 10.3390/ijms232213687. Int J Mol Sci. 2022. PMID: 36430166 Free PMC article.
Q586B2 is a crucial virulence factor during the early stages of Trypanosoma brucei infection that is conserved amongst trypanosomatids.
Stijlemans B, De Baetselier P, Van Molle I, Lecordier L, Hendrickx E, Romão E, Vincke C, Baetens W, Schoonooghe S, Hassanzadeh-Ghassabeh G, Korf H, Wallays M, Pinto Torres JE, Perez-Morga D, Brys L, Campetella O, Leguizamón MS, Claes M, Hendrickx S, Mabille D, Caljon G, Remaut H, Roelants K, Magez S, Van Ginderachter JA, De Trez C. Stijlemans B, et al. Among authors: vincke c. Nat Commun. 2024 Feb 27;15(1):1779. doi: 10.1038/s41467-024-46067-4. Nat Commun. 2024. PMID: 38413606 Free PMC article.
Nanobodies and their potential applications.
Hassanzadeh-Ghassabeh G, Devoogdt N, De Pauw P, Vincke C, Muyldermans S. Hassanzadeh-Ghassabeh G, et al. Among authors: vincke c. Nanomedicine (Lond). 2013 Jun;8(6):1013-26. doi: 10.2217/nnm.13.86. Nanomedicine (Lond). 2013. PMID: 23730699 Free article.
59 results